Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04817_nanopub.RAY5hwZIoJZaK4P3J0K_AfS7_2uqmDfj_WAnIiKK40rVM#assertion>. }
Showing items 1 to 17 of
17
with 100 items per page.
- drugbank:DB04817 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04817 label "Metamizole [drugbank:DB04817]" assertion.
- drugbank:DB04817 seeAlso DB04817 assertion.
- drugbank:DB04817 identifier "drugbank:DB04817" assertion.
- drugbank:DB04817 description "Metamizole, formerly marketed as Dimethone tablets and injection, Protemp oral liquid, and other drug products, was associated with potentially fatal agranulocytosis. Approvals of the NDA's for dipyrone drug products were withdrawn on June 27, 1977 (see the Federal Register of June 17, 1977 (42 FR 30893)). Withdrawn from the Canadian market in 1963." assertion.
- drugbank:DB04817 title "Metamizole" assertion.
- drugbank:DB04817 bio2rdf_vocabulary:identifier "DB04817" assertion.
- drugbank:DB04817 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04817 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04817" assertion.
- drugbank:DB04817 bio2rdf_vocabulary:x-identifiers.org DB04817 assertion.
- drugbank:DB04817 drugbank_vocabulary:drugbank-id "DB04817" assertion.
- drugbank:DB04817 drugbank_vocabulary:x-cas cas:50567-35-6 assertion.
- drugbank:DB04817 drugbank_vocabulary:x-chemspider chemspider:6000 assertion.
- drugbank:DB04817 drugbank_vocabulary:x-pubchemcompound pubchem.compound:522325 assertion.
- drugbank:DB04817 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:46509035 assertion.
- drugbank:DB04817 drugbank_vocabulary:x-chebi chebi:25979 assertion.
- drugbank:DB04817 drugbank_vocabulary:x-wikipedia wikipedia:Dipyrone assertion.